Back to Awarded Treatment Trials
Awarded Trial: 07TGF-1102
Grant ID
07TGF-1102
Illness
schizophrenia
Primary Drug/Intervention
omega-3
Primary Dosage
N/A
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Completed
Investigator
McGorry
Sample Size
280
Duration of Study Period for Each Subject
N/A
Outcome Measurements
N/A
Results
304 subjects at ultra-high risk (UHR) for a psychotic disorder were randomized to receive 1.4 g/day omega-3 fatty acids or placebo in addition to cognitive behavioral case management for six months. The study was to determine the transition status to first episode psychosis (FEP). At 12 months, the overall transition rate was lower than expected at 10.5% (32 of 304), and no significant differences in the rate of transition to psychosis were found between the two study groups. A longer-term follow-up of this cohort is underway.
Publication
N/A
Link
N/A
PI Name
Patrick McGorry
Degree
N/A
Center
N/A
Institution
ORYGEN Research Centre
Address
35 Poplar Road
City or Town
Parkville
State or Province
VIC
Zip or Postal Code
3052
Country
Australia
Email Address
pmcgorry@unimelb.edu.au